The timely diagnosis of prosthetic heart valve endocarditis remains challenging yet of utmost importance. introduced as additional diagnostic tools in the most recent ESC guidelines on infective endocarditis. However, how to interpret PET/CT findings with regard to what is to be considered abnormal, what the potential confounders may be, as well as which patients benefit most from these additional imaging techniques and how to best perform them in these often-complex patients, remains unclear. This review focusses on factors regarding patient selection and image acquisition that need to be taken into account when employing 18
Introduction
Over 300 000 prosthetic heart valves (PHVs) are implanted worldwide every year. Besides the immediate risk of prosthesis-patient mismatch and the long-term risk of well-known complications such as thromboembolic events and structural valve deterioration, another serious condition with a very high mortality rate (30-50%) affects patients with PHVs at an incidence of approximately 0.3-1.2% per patient-year: prosthetic heart valve endocarditis (PVE). [1] [2] [3] Despite ongoing advances in echocardiographic imaging and diagnostic microbiology, the diagnosis of PVE remains challenging, mostly because echocardiography and blood cultures (as mainstays of the Modified Duke Criteria) 4 are inconclusive in more than 20% of PVE episodes, especially in the early stages of the disease. 5 Combined with an atypical clinical presentation, the consequent delay or inappropriateness of treatment can lead to extensive perivalvular structural damage and systemic complications, worsening patient outcomes, and increasing risk of recurrence. 6 tomography (PET/CT) and cardiac computed tomography angiography (CTA) were recently introduced as additional tools to diagnose PVE, and added to the diagnostic criteria in the most recent ESC guidelines for infective endocarditis. 6 The two largest prospective studies to date have shown decent diagnostic accuracy of PET/CT alone, and an improved performance of the entire diagnostic workup when PET/CT and CTA were added to it. 7, 8 However, randomized controlled trials are lacking, and how to interpret PET findings with regard to what is to be considered abnormal, what the potential confounders may be, as well as which patients benefit most from these additional imaging techniques and how to best perform them in these often-complex patients, remains unclear. This review focusses on factors regarding patient selection and image acquisition that need to be taken into account when employing 18 F-FDG PET/CT and CTA in daily clinical practice, and emphasizes the need for standardized acquisition protocols and image interpretation, especially now that these techniques are starting to be widely embraced by the cardiovascular society.
Implementation in the diagnostic work-up of suspected prosthetic heart valve endocarditis
The 2015 ESC Guidelines on Endocarditis recommend using additional imaging modalities when echocardiography and blood cultures are inconclusive (i.e. result in a 'possible' diagnosis of endocarditis, or a 'rejected' diagnosis with persisting high suspicion). Three techniques may be employed: CTA to depict perivalvular complications, cerebral magnetic resonance imaging (MRI), and/or whole-body CT or PET/ CT to depict embolic events, and-only in case of PHVs- 18 F-FDG PET/CT to evaluate abnormal metabolic activity around the site of prosthetic valve implantation, 6 as evidence on the use of 18 F-FDG PET/CT in patients with native valve endocarditis is merely limited and non-supporting. For PHVs, no distinction is made between biological and mechanical prosthetic valves, as PET/CT performance does not differ between the two valve types. 7, 8 Evidence of its use in patients suspected of transcatheter-replaced aortic valves (TAVR) endocarditis is still limited to case reports, 9 but may soon become relevant as the incidence of TAVR endocarditis has been increasing over the past decade and mortality is high. 10 The ESC guidelines recommend cardiac CTA and 18 F-FDG PET/ CT only to be employed when diagnostic uncertainty remains after the usual diagnostic work-up comprising echocardiography and blood cultures. 6 One problem with this approach is the consequential delay of additional imaging, sometimes after several weeks of antibiotic therapy. The resulting decrease in inflammatory activity directly affects the intensity of 18 F-FDG uptake around the infected prosthetic valve. 11 Moreover, there are other valid reasons to consider both PET/CT and CTA, even when the Modified Duke criteria have already been met ( Figure 1) . For PET/CT, these reasons include the possibility of depicting metastatic infections and septic emboli, identification of the focus of infection (port of entry), evaluation of involvement of other valves or cardiac implanted electronic devices, and identification of other foci of infection should PVE be ruled out, all of which may guide treatment strategies. For CTA, besides the ability to depict oedema as an early sign of inflammation (seen as stranding of the fatty tissue around the annulus and ascending aorta), the detailed anatomical depiction in all cardiac phases offers superior detection of perivalvular extensions such as abscesses and pseudoaneurysms. 12, 13 Since the presence and extent of such perivalvular extensions often guides the decision to surgically intervene, clear depiction of these life-threatening complications is of the utmost importance and simultaneously provides valuable anatomical information for planning of the surgical approach. 2 Either technique, but 18 F-FDG PET in particular, can detect inflammation before structural changes (i.e. vegetations, perivalvular extensions, etc.), which are required for echocardiographic detection of PVE, ensue, while also allowing for early detection of septic emboli and metastatic infections before these become clinically apparent. [14] [15] [16] This further increases the importance of their early implementation in the diagnostic work-up, as they may allow for diagnosis and initiation of appropriate antibiotic therapy in the earlier stages of the disease, before extensive damage (or vegetational growth) that may require a major surgical (re)intervention has occurred. The optimal timing of employment of PET/CT and CTA however, is not absolute, and the benefits of the additional information gained should be weighed against the downsides of exposure to radiation and intravenous contrast, however small these may often be in light of the morbidity associated a missed diagnosis or an unidentified complication. Acquiring a PET-scan in a critically ill patient may, just like TEE, be problematic, in which case assessment by CTA alone for complications requiring immediate care may be preferential, further underlining the importance of a patient-tailored diagnostic approach in every case of suspected PVE. Combined with the expertise, advanced scanning equipment and broad reference framework required for the acquisition and interpretation of PET/CT and CTA images in suspected PVE, this emphasizes the need for a multidisciplinary Endocarditis Team in surgical reference centres. 6 Early consultation with-or referral to-this team is essential for any patient suspected of endocarditis, particularly in case of suspected PVE, and should take place as soon as the initial diagnostic work-up comprising a clinical evaluation, blood cultures and (transthoracic and transoesophageal) echocardiography has been completed ( Figure 1) .
Methods of acquisition
Some of the largest studies performed to date have simply adopted the oncological total-body PET protocol, in which, after a 6-h fast, a dose of 18 F-FDG based on the patients' body weight is injected 60 min prior to image acquisition. Although alternative post-injection acquisition timings have been suggested for the detection of PVE, there is no substantial evidence that supports an earlier or a delayed acquisition. 17, 18 However, to adequately assess the heart, some other important adaptations are required.
PET patient preparation
Fasting and low-carbohydrate diet Under normal circumstances, the heart metabolizes both carbohydrates and free fatty acids (FFAs), thus also taking up an ample amount of 18 F-FDG which often makes evaluation of (prosthetic)
. heart valves and the peri-annular areas difficult and cannot sufficiently be prevented by regulation of blood glucose levels alone. 19 Prolonged fasting (up to 18 h) and a low-carbohydrate diet suppress myocardial 18 F-FDG uptake as they reduce the amount of glucose available for myocardial metabolism, making FFAs the predominant cardiac energy source. 20 However, no standardized preparatory protocol exists. The duration of the pre-scan fasting period and the way in which a preparatory diet (if any) was applied, varied widely within studies performed to date. From a number of studies on the use of 18 F-FDG PET/CT in cardiac sarcoidosis however, it seems the longer the fasting period, the better the myocardial suppression, 21 and combined fasting for at least 12 h and a 24-h low-carbohydrate diet is likely superior to either one alone ( Figure 2 ).
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Intravenous heparin injection
To further decrease myocardial 18 F-FDG uptake, intravenous heparin has been proposed. 23 Figure 2) .
24,25
CT angiography
The low-dose localization CT acquired on the PET/CT-scanner cannot be used for diagnostic purposes. Since depiction of PHVs requires contrast enhancement, ECG-gating and a high temporal resolution, an additional CTA is required. Although co-registration on one integrated scanner with breathing-and ECG-gated PET is preferred as it provides more reliable image fusion and is feasible on current state-of-the-art PET/CT scanners, the required CTA image quality and temporal resolution may require a separate scan with post hoc fusion on a high-end dedicated CTA scanner in centres with less advanced PET/CT equipment. Fusion of PET and CTA images allows for better anatomical correlation (see Supplementary material online, Figure S1 , Video S1), and can help differentiate sterile paravalvular extensions 9 (e.g. those that are a result of surgery or previous endocarditis) from mycotic aneurysms and abscesses (see Supplementary material online, Figure S2 ), which may help guide the surgical approach in case a reoperation is required. Most PHVs cause only limited artefacts on CT images. 26 Adjusted double-oblique planes provide short-axis views of the prosthetic valve, as well as perpendicular views of the valve leaflets that allow for a more detailed assessment of vegetations and mechanical valve function (e.g. opening and closing angles of bi-leaflet valves). 26, 27 In most patients, even the presence of coronary artery disease and the patency of coronary bypass grafts can readily be evaluated, 28 which is of particular importance in aortic PVE that requires reoperation, as 
vegetations may be dislodged due to catheter manipulation during invasive coronary angiography ( Figure 3) .
While the contrast-enhanced acquisition is the most important, an additional non-contrast-enhanced acquisition may be helpful to assess calcifications and suture pledgets. A prospectively ECGtriggered scan of the PHV, similar to a calcium score scan, at 45% of the RR interval is often sufficient (Figure 3) . Finally, a delayed venousphase acquisition of the entire chest may be helpful to detect wall enhancement of abscesses and differentiate thrombus from slow flow, but can be challenging to acquire and has not been sufficiently validated yet.
Total radiation dose
With the average PET/CT radiation dose varying from approximately 5-15 mSv (depending on the administered amount of 18 F-FDG) and an approximate dose of 5-10 mSv for a dynamically ECG-gated or triggered CTA of the heart, the total radiation dose approaches 15-20 mSv, 8 which is high but, in light of the mortality associated with PVE and (missed) perivalvular extensions in particular, seems acceptable when considering the possible benefits of early diagnosis and adequate treatment that can be achieved by combining these imaging modalities. Future technological advancements, new (iterative) reconstruction techniques and prospective CTA protocols specifically tailored for the acquisition of PHVs may allow further reduction of this radiation dose.
29,30
Image interpretation
Scatter-corrected PET-images with and without correction for attenuation by surrounding tissues and scattering (based on the lowdose CT) can be viewed separately in all planes, as a maximum intensity projection or fused with the low-dose CT images. Besides the full-body assessment of any pathological 18 F-FDG uptake, both a visual and a (semi-)quantitative evaluation of the PHV(s) should be performed. Finally, there are several patient and acquisition related factors that could result in either false positive or false negative misinterpretations and need to be taken into account.
Qualitative assessment
Through visual analysis, regions with pathological 18 F-FDG uptake are identified as areas of increased signal intensity, i.e. a higher intensity than may be expected, usually shown as bright or 'hot' colours on fused images. Based on the density of tissues around the point of interest as determined by the low-dose CT, the signal is amplified depending on the amount of attenuating material between the source (i.e. the location of the 18 F-FDG) and the PET camera (attenuation correction). In case of PHV, the metallic components are identified as having a very high density, which may result in overamplification of the signal originating from regions around or 'behind' the prosthetic valve. Therefore, when an abnormal focus of 18 F-FDG uptake is identified surrounding a prosthetic heart valve, correlation with the non-attenuation-corrected images is advised, as the combination of visual assessment of both the corrected and non-corrected images has the highest diagnostic 
accuracy for PVE. 31 As long as the pathological uptake remains distinguishable from the surrounding background on the non-attenuationcorrected images, the intensity of the signal seems to be less relevant for diagnostic purposes. 31 Alternatively, metal-artefact reducing algorithms have recently been suggested to help reduce the erroneous overcorrection for attenuation in case of cardiac implantable electronic devices, 32 but these have not yet been tested with PHV.
The assessment of abnormal 18 F-FDG uptake around PHV is not dichotomous. Different patterns of uptake with different intensities can be found, and always have to be evaluated in light of clinical parameters such as the duration of antibiotic therapy prior to imaging since the clinical relevance of these different patterns is not yet fully understood (Figure 4) . 33 In bioprosthetic valves with struts, slightly increased 18 F-FDG uptake around these metallic components is sometimes observed, possibly due to chronic tension or friction exerted on these anchor points. 34, 35 Quantitative analysis
To reduce observer subjectivity, several studies to date have attempted to add a quantitative analysis to the visual evaluation of PHVs for suspicion of PVE. Standardized uptake values are commonly used in PET-imaging to express the amount of 18 F-FDG uptake in a particular region of interest relative to the amount of injected radioactivity (assuming an even distribution throughout the body; corrected for body mass index or lean body mass).
Use of a spherical volume of interest around the prosthetic heart valve to measure the maximum signal intensity may prove troublesome when this volume includes any residual 18 F-FDG uptake in the myocardium or ascending aorta. An automated volume of interest expanding to a certain percentage (e.g. 40%) of the amount of 18 F-FDG uptake measured at the point of maximum intensity, with manual correction if necessary, may therefore be a more sensible approach ( Figure 5) .
Several studies attempted to establish cut-off values for the measured maximum intensity around the PHV (SUV max ). However, since the SUV max is dependent on a number of variables including the amount of injected 18 F-FDG in relation to the body weight of the patient, the camera of the scanner and scanning parameters (such as time per bed position), an alternative measure of relative 18 F-FDG uptake has also been advocated, which is not affected as much by Often during implantation, surgical felt pledgets (arrows) may be used to strengthen the annulus (C) onto which the prosthetic heart valve is sutured (asterisk), which have a similar density as iodinated contrast on computed tomography angiography and may therefore mimic perivalvular extensions (B, arrows). An additional non-contrast enhanced scan (E) will allow differentiation between the two. On a three-dimensional volumetric rendering (F), a visual impression of valve function and possible 'rocking' of the valve (in case of dehiscence) can be gained.
these parameters: the ratio of the uptake around the PHV to the background activity measured in the blood pool (e.g. in the descending aorta or adjacent venous system). Even this SUV ratio still lacks generalizability though, mostly due to differences in cameras, imaging protocols and reconstruction methods between centres, hence the widely spread suggested cut offs for both parameters (see Tables 1  and 2) .
To partially overcome this issue, a standardized calibration and reconstruction method has been introduced by the European Association of Nuclear Medicine Research Ltd (EARL) which adapts the quantified uptake relative to the uptake measured in a phantom. Over 100 centres currently have their accreditation.
Positive confounding factors
Recent valve implantation Increased 18 F-FDG uptake due to (physiological) inflammation after recent surgery, irradiation, or chemotherapy, is a well-known pitfall causing false positive misinterpretations in oncological PET imaging. 36 For PHV surgery, the duration and characteristics (i.e. uptake pattern, Figure 4 ) of postoperative periprosthetic inflammation remains unclear. Some cases of increased 18 F-FDG uptake around recently (<2 months) implanted valves have been reported ( Figure 6A) . 37 Therefore, the ESC guidelines do not currently recommend 18 F-FDG PET/CT for suspicion of PVE within 3 months of PHV implantation.
More recently however, the arbitrarity of this three month grace period was underlined, as many true negatives have been reported even within 1 month of valve implantation, as well as several false positives beyond the first three post-operative months, 18 further exemplifying the need for future research to elucidate the exact duration and especially the characteristics of postoperative inflammation on PET/CT, as well as its influencing factors (i.e. valve type, implantation technique, etc.).
As an alternative imaging technique to 18 F-FDG PET/CT that is also mentioned in the ESC guidelines, 6 radiolabeled leucocyte scintigraphy employs in-vitro labelling of autologous leucocytes with radioactive markers such as 99m Technetium analogues to detect inflammation. In a study that compared both techniques in 39 patients with suspected PVE, PET/CT had a low specificity and positive predictive value of 71% and 68% respectively. 38 However, all of the six false positive results were identified in patients who had undergone openchest cardiac surgery <2 months prior to 18 F-FDG PET/CT imaging. Radiolabeled leucocyte scintigraphy was not affected by postoperative inflammation and was thus true-negative in all of these patients, suggesting a sequential strategy consisting of both modalities could be feasible in patients with suspicion of a false positive PET/CT result due to recent valve implantation. Radiolabeled leucocyte scintigraphy did, however, substantially compromise sensitivity in this study and is generally very time-consuming and labour-intensive, which limits clinical applicability. (Figure 2) . Especially the basal lateral and septal wall may often show persisting myocardial 18 F-FDG uptake despite prolonged fasting that, when close to a prosthetic aortic or mitral valve, can possibly mimic uptake also observed in cases of PVE ( Figure 6B) . 22, 25 Semi-quantitative analyses using spherical volumes of interest around these PHV are practically unfeasible. 34 Fusion with CTA may provide improved delineation of the prosthetic valve and allow for better differentiation of pathological periprosthetic 18 F-FDG uptake from residual myocardial 18 F-FDG uptake. 8 
Surgical adhesives
Surgical adhesives used during cardiac surgery can be very FDG-avid for undetermined but extended periods of time, possibly due to an inflammatory foreign body reaction ( Figure 6C) . They have previously been reported to result in false positive PET misinterpretations after aortic root surgery 39 and heart valve replacement. 34 Other patient and image processing related artefacts Movement of the heart and the patient during PET acquisition, as well as erroneous fusion of PET and CT images, may displace or spread extracardiac (e.g. pulmonary) or unsuppressed myocardial 18 F-FDG uptake and project it adjacent to a PHV, resulting in false positive misinterpretations. As stated earlier, both overcorrection due to beam hardening next to a PHV as well as 'normal' slightly increased uptake due to possible strain exerted by sutures or PHV struts can also lead to false-positive misinterpretations.
Negative confounding factors Prolonged antibiotic therapy
In the prospective cohort study by Saby et al., 7 eight out of 30 (26%) patients with a definite final diagnosis of PVE had negative PET/CT results. Echocardiography was positive for endocarditis in all eight patients, but blood cultures were negative in three. None of the reported variables were statistically significant predictors of a negative PET/CT, yet the authors stated that these false negative results
Figure 5
Semi-quantitative analysis of periprosthetic 18 F-fluorodeoxyglucose uptake in a patient with excellent suppression of myocardial 18 F-fluorodeoxyglucose uptake (A) and a patient with some residual myocardial 18 F-fluorodeoxyglucose uptake (B). Through a combination of manual avoidance of unsuppressed myocardium (asterisk, B1), and the use of an automated volume of interest created as an isocontour of all voxels that have an intensity of at least 40% of the voxel with the highest intensity in the selected area (bottom), the maximum standardized uptake value around the prosthetic heart valve is reliably and reproducibly measured. The maximum standardized uptake value is then divided by the mean standardized uptake value of a small spherical volume of interest placed in the blood pool of the descending aorta at the level of the prosthetic valve (small enough to guarantee exclusion of any aortic wall) to calculate the ratio of standardized uptake value (bottom). SUC, standardized uptake value.
could be attributed to lower inflammatory activity and PET/CT being performed after extended periods of antibiotic therapy in these cases. 7 One could even argue that the PET-scan is not false negative, but in fact true negative for active infection, as the inflammation is suppressed by the antibiotics. Thus, a certain level of inflammatory activity is required for accurate PET results, as illustrated by two studies that showed significantly improved diagnostic accuracy of PET for fever of unknown origin when C-reactive protein levels were elevated. 40, 41 Early implementation of PET/CT(A) in the diagnostic work-up of patients with suspected PVE may therefore not just improve outcome by allowing for a timelier diagnosis, but may also prevent missed diagnoses due to extended periods of antibiotic therapy.
Vegetations Isolated, small, or mobile vegetations have been reported to be missed by 18 F-FDG PET/CT due to its limited temporal and spatial resolution 42 , and because vegetations mostly consist of dense fibrous residue which shields the pathogen from a cellular immune response 43 , as illustrated by some cases of larger vegetations also being PET-negative. 44 This further underlines the need for a multimodality approach in which each imaging modality covers the other's possible shortcomings, as vegetations are readily detected on CTA.
Metastatic infections and incidental findings
Before 18 F-FDG PET/CT was introduced for the diagnosis of infective endocarditis itself, it was already being used to detect septic emboli- 3) (P = 0.02) n/a n/a n/a n/a Tanis et al. 46 7 1 8.4 (7.2-9.7) 2.2 n/a n/a n/a n/a Rouzet et al. n/a n/a n/a n/a Salomäki et al. 43 reported that two scans were false-positive, one due to a foreign body reaction, the other most likely due to recent valve implantation (6 weeks). These two scans, with respective SUV max values of 7.1 and 7.8, were excluded in this table.
. Mathieu et al. 35 0 54 n/a 2.0 (1.3-6.6) n/a n/a n/a n/a particularly asymptomatic ones-and metastatic infections. 15 In fact, septic emboli detected by additional imaging techniques including 18 F-FDG PET, whole body CT(A) and (cerebral) MRI have now been added as a minor diagnostic criterion in the latest guidelines. 6 Any extracardiac focus is likely to be identified by 18 F-FDG PET/CT if performed in the early stage, before prolonged antibiotic therapy. 46 Moreover, when no pathological 18 F-FDG uptake is identified around a PHV, 18 F-FDG PET/CT may provide an alternative diagnosis in up to 54% of the patients with a rejected diagnosis of PVE. 8 Interpretation of findings and decisionmaking: role of the 'Endocarditis Team'
The PET/CT and CTA findings should be correlated to clinical and other diagnostic findings. Ideally-and according to the most recent ESC guidelines-, findings of blood cultures, (transthoracic and transesophageal) echocardiography, CT angiography, PET/CT, and other imaging modalities tailored to suspicion of complications such as septic emboli (e.g. abdominal or whole-body CT, brain CT or MR) are to be discussed in a multidisciplinary 'Endocarditis Team'. This team (in a tertiary care centre with cardiothoracic surgical capabilities) should have regular meetings and consist of at least a cardiologist, cardiothoracic surgeon, microbiologist and/or infectious disease specialist, radiologist and/or nuclear medicine physician. 47 Due to the complexity of the disease itself, and the acquisition and interpretation of often-required additional imaging in particular, referral to a reference centre with such an expert team shouldbesides in cases of complicated endocarditis, as the guidelines recommend-readily be considered in any case of PVE.
Future perspectives
The possibilities of using PET as a tool to follow-up on antibiotic therapy and possibly even guide decisions such as treatment prolongation (or a surgical approach) have been debated in other studies employing PET for the detection of infectious or inflammatory disease. 48, 49 However, keeping in mind the negative confounding effect of prolonged antibiotic therapy on the diagnosis of PVE using PET, it remains questionable whether it can in fact accurately distinguish suppressed infection from complete eradication. 11 Alternatively, some case reports have shown that even in successful antibiotic treatment of PVE, follow-up PET/CT may still, albeit less intense, show abnormal 18 F-FDG uptake around the PHV despite uneventful clinical follow-up, once more exemplifying that inflammation does not necessarily imply infection. 9 Lack of an adequate reference standard has been problematic in all trials to date. With an estimated sensitivity and specificity of the Modified Duke Criteria in PVE of approximately 60-70%, the diagnostic performance of PET can hardly be adequately assessed, while an alternative reference standard based on expert consensus, as in the largest prospective cohort studies to date, results in a substantial incorporation bias due to the experts not being blinded to PET/CT findings.
The goal should not be to replace routine PVE diagnostics, but rather to employ PET/CT and CTA on top of the current standard of care. However, it should not be reserved just for the most complicated cases in which current diagnostics fall short and uncertainty remains. Prospective trials that employ standardized acquisition methods in the early diagnostic work-up of patients with PVE can then assess the true diagnostic accuracy of PET/CT, and may even be able to determine possible cut-off (i.e. maximum SUV or SUV ratio) values for quantitative PET analysis.
Conclusion
18
F-FDG PET/CT is a very promising novel diagnostic tool for patients suspected of having PVE, as it allows for a most accurate and timely diagnosis. When combined or even fused together with cardiac CT angiography, it provides a complete assessment of structural and functional abnormalities, as well as any concomitant coronary artery disease and the optimal surgical approach, should a reoperation be required.
All studies to date have mostly been limited by both the lack of an adequate reference diagnostic and the absence of standardized image acquisition and interpretation methods, either of which may have even resulted in underestimation of the true diagnostic accuracy of these imaging modalities. Early-if not routine-implementation in the clinical work-up combined with standardization of imaging protocols and both visual and quantitative analysis will allow future larger, prospective, multicentre studies to further evaluate the full diagnostic potential of 18 F-FDG PET/CT(A) in patients with suspected PVE, and allow for better generalizability of their results to daily clinical practice.
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